SAS-B figures show patients are getting younger, ‘maler’ and more anxious

In the first of a new series, we take a deep dive into the Therapeutic Goods Administration’s SAS-B medicinal cannabis access data dashboard to find out what’s really going on in the industry. This service is available exclusively to Cannabiz premium members. To upgrade your membership and access this article, click here.

Medicinal cannabis patients are getting younger, ‘maler’ and more anxious, though their preference for flower has not been enough to knock oil off its perch, according to TGA data for the first four months of 2022.